Utama › Kolesterol › Texas
Kajian klinikal Kolesterol di Texas
6 kajian untuk Kolesterol sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
- Austin Heart, Austin
- dan 8 lagi
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 130 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research Dallas, Dallas
- Valley Institute of Research, Rockwood Medical Clinic, Fort Worth
- Be Well Clinical Studies - Round Rock, Round Rock
- dan 3 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Jul 2026 · NCT07477704Multicomponent Intervention Study- Blood Donors With High Cholesterol
- UT Southwestern Medical Center, Dallas
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Mac 2026 · NCT05693701Alirocumab in Patients on a Stable Dialysis Regimen
- Baylor Soltero CV Research, Dallas
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Feb 2020 · NCT03480568Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.